Search

Your search keyword '"Butzow, Ralf"' showing total 596 results

Search Constraints

Start Over You searched for: Author "Butzow, Ralf" Remove constraint Author: "Butzow, Ralf"
596 results on '"Butzow, Ralf"'

Search Results

1. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

2. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

3. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

4. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

5. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

6. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

7. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

8. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

9. Shared heritability and functional enrichment across six solid cancers.

10. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

11. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

12. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study

13. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

14. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

15. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

16. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

17. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

18. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

19. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

20. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

21. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

22. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)

23. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

24. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

25. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.

26. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

27. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.

28. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.

29. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

30. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

31. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

32. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

33. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

34. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

35. Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

36. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

37. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

38. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

39. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

40. Common variants at 19p13 are associated with susceptibility to ovarian cancer.

42. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

43. Evidence of a genetic link between endometriosis and ovarian cancer

44. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

45. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

46. Supplementary Figure from Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype

47. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

48. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

49. Supplementary Data from Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype

50. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

Catalog

Books, media, physical & digital resources